Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acid esters
Reexamination Certificate
2007-04-03
2007-04-03
Tucker, Zachary C. (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acid esters
Reexamination Certificate
active
10656567
ABSTRACT:
The present invention provides a method for producing an enantiomerically enriched α-(phenoxy)phenylacetic acid compound of the formula (I):from its enantiomeric mixture, where R1is alkyl or haloalkyl R7is heteroalkyl and X is halide.
REFERENCES:
patent: 3378582 (1968-04-01), Bolhofer
patent: 3444299 (1969-05-01), Wood et al.
patent: 3469009 (1969-09-01), Klingbail
patent: 3517050 (1970-06-01), Bolhofer
patent: 3517051 (1970-06-01), Bolhofer
patent: 3558778 (1971-01-01), Klingbail
patent: 3658829 (1972-04-01), Nakamura et al.
patent: 3674836 (1972-07-01), Creger
patent: 3860628 (1975-01-01), Shuman
patent: 3876791 (1975-04-01), Hubbard et al.
patent: 3923855 (1975-12-01), Shuman
patent: 3953490 (1976-04-01), Shuman
patent: 4001268 (1977-01-01), Kovar et al.
patent: 4067996 (1978-01-01), Najer et al.
patent: 4146623 (1979-03-01), Parker
patent: 4214095 (1980-07-01), Thiele et al.
patent: 4250191 (1981-02-01), Edwards
patent: 4338330 (1982-07-01), Gillet et al.
patent: 4508882 (1985-04-01), Yoshida et al.
patent: 4528311 (1985-07-01), Beard et al.
patent: 4532135 (1985-07-01), Edwards
patent: 4714762 (1987-12-01), Hoefle et al.
patent: 4786731 (1988-11-01), Russell
patent: 4863802 (1989-09-01), Moore et al.
patent: 4891396 (1990-01-01), Avar et al.
patent: 4910211 (1990-03-01), Imamura et al.
patent: 4933367 (1990-06-01), Wolff et al.
patent: 5132429 (1992-07-01), Narita et al.
patent: 5284599 (1994-02-01), Iwaki et al.
patent: 5476946 (1995-12-01), Linker et al.
patent: 5496826 (1996-03-01), Watson et al.
patent: 5500332 (1996-03-01), Vishwakarma et al.
patent: 5516914 (1996-05-01), Winter et al.
patent: 5554759 (1996-09-01), Vishwakarma
patent: 5700819 (1997-12-01), Aotsuka et al.
patent: 5716987 (1998-02-01), Wille
patent: 5766834 (1998-06-01), Chen et al.
patent: 5859051 (1999-01-01), Adams et al.
patent: 5874431 (1999-02-01), Stevens et al.
patent: 5883124 (1999-03-01), Samid
patent: 5942626 (1999-08-01), Winter et al.
patent: 6013659 (2000-01-01), Goldfarb et al.
patent: 6034246 (2000-03-01), Stevens et al.
patent: 6037493 (2000-03-01), Mathey et al.
patent: 6069272 (2000-05-01), Crout et al.
patent: 6093830 (2000-07-01), Yadav et al.
patent: 6184235 (2001-02-01), Connor et al.
patent: 6201000 (2001-03-01), Luther et al.
patent: 6201147 (2001-03-01), Bornscheuer et al.
patent: 6242464 (2001-06-01), Haris et al.
patent: 6248768 (2001-06-01), Yamada et al.
patent: 6262118 (2001-07-01), Luskey et al.
patent: 6506747 (2003-01-01), Betageri et al.
patent: 6613802 (2003-09-01), Luskey et al.
patent: 6624194 (2003-09-01), Luskey et al.
patent: 6646004 (2003-11-01), Luskey et al.
patent: 6670395 (2003-12-01), Wille
patent: 2003/0220399 (2003-11-01), Luskey et al.
patent: 2004/0039053 (2004-02-01), Luskey et al.
patent: 2004/0204472 (2004-10-01), Briggs
patent: 2005/0033084 (2005-02-01), Daugs
patent: 2005/0075396 (2005-04-01), Luskey et al.
patent: 967978 (1975-05-01), None
patent: 0 077 938 (1983-05-01), None
patent: 0 105 494 (1984-04-01), None
patent: 0 306 708 (1989-03-01), None
patent: 1 162 196 (2001-12-01), None
patent: 1476525 (1967-04-01), None
patent: 1182008 (1970-02-01), None
patent: 1403309 (1975-08-01), None
patent: 53-15325 (1978-02-01), None
patent: 53-71071 (1978-06-01), None
patent: 60-109578 (1986-06-01), None
patent: WO 92/17435 (1992-10-01), None
patent: WO 98/23252 (1998-06-01), None
patent: WO 99/11627 (1999-03-01), None
patent: WO 00/35886 (2000-06-01), None
patent: WO 00/74666 (2000-12-01), None
patent: WO 02/44113 (2002-06-01), None
patent: WO 04/112774 (2004-12-01), None
Jean Jacques and André Collet Enantiomers, Racemates, and Resolutions, pp. 307-328 © 1981 by John Wiley & Sons, Inc.
Read and Reid, “The Complete Optical Resolution of Externally Compensated Acids and Bases” Journal of the Society of the Chemical Industry—London, vol. 47, pp. 8T-11T (1928).
Aronow, W.S. et al., “Effect of halofenate on serum uric acid,”Clin. Pharmacol. Ther., 1973, vol. 14, pp. 371-373.
Aronow, W.S., et al., “Halofenate: An Effective Hypolipemia- and Hypouricemia-Inducing Drug”, Current Therapeutic Research, 1973, vol. 15, No. 12, pp. 902-906.
Bardin, C.W., eds., Current Therapy in Endocrinology and Metabolism, 6th Edition, Mosby - Year Book, Inc., St. Louis, MO, 1997, pp. 509-519.
Barrett-Conner, “Epidemology, Obesity, and Non-Insulin-Dependent Diabetes Mellitus”, Epidemol. Rev., 1989, vol. 11, pp. 172-181.
Bassett, D.R., et al., “Effects of halofenate and probenecid in serum lipids and uric acid in hyperlipidemic, hyperuricemic adults,” Clin. Pharmacol. Ther. 1977, vol. 22, No. 3, pp. 340-351.
Bell, G., et al., “Glucokinase Mutations, Insulin secretion, and Diabetes Mellitus,” Annu. Rev. Physiol., 1996, vol. 58, No. pp. 171-187.
Berkow, R., Chapter 94, “Disorders of Carbohydrate Metabolism,” The Merck Manual of Diagnosis and Therapy 15th ed.,Merck Sharp & Dohme Research Laboratories, 1987, pp. 1069-1072.
Bluestone, R., et al., “HalofenateIts Selection and Trial as a Primary Uricosuric Agen”t, Arthritis Rheum., 1975, vol. 18, pp. 859-862.
Brooks, D., et al., “Design and Synthesis of 2-Methyl-2-4{(4-(2-(5-methyl-2-aryloxazol-4-yl)ethoxy}phenoxy'-propionic Acids: A New Class of Dual PPARα/y Agonists, ” J. Med. Chem., 2001, vol. 44, pp. 2061-2084.
Chiasson, J., et al., “The Efficacy of Acarbose in the Treatment of Patients with Non-Insulin-dependant Diabetes Mellitus,” Annals of Intern. Med., 1994 vol. 121, No. 12, pp. 928-935.
Coniff, R., et al., “Acarbose: A Review of US Clinical Experience,” Clinical Therapeutics, 1997, vol. 19, No. 1, pp. 16-26.
Coniff, R., et al., “Multicenter, Placebo-Controlled Trial Comparing Acarbose (BAY g 5421) With Placebo, Tolbutamide, and Tolbutamide-Plus-Acarbose in Non-Insulin-Dependent Diabetes Mellitus,” The American Journal of Medicine, 1995, vol. 98, pp. 443-451.
Diamant, M., et al., “Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence,” Drugs, 2003, vol. 63, pp. 1373-1405. ABSTRACT.
Dorfler, H., “Primarer Verteilungraum and Plasmahalbwertszeit von intravenos verbreichtem Insulin,” Med. Poliklinik Univ. Muchen, 1973, pp. 1297-1299.
Edelman, S.V., et al., “Non-Insulin-Dependent Diabetes Mellitus”, Current Therapy in Endocrinology and Metabolism, 1997, pp. 430-438.
El-Sherief, et al., “Synthesis and Antimicrobial Activities of Some New Benzimidazoles, Part 1,” Bull. Fac. Sci. Assiut Univ. B, 1995, vol. 24, No. 1, pp. 111-123.
Fajans, S., et al., “Maturity Onset Diabetes of the Young (MODY)” Diabetes Medicine, 1996, vol. 13, pp. S90-S95.
Fanelli, G.M., Jr., “Renal Excretion and Uricosuric Properties of Halofenate A Hypolipidemic Uricosuric Agent in the Chimpanzee,” J. Pharmacol. Exp. Ther. 1972, vol. 180, pp. 377-396.
Feldman, E.B., et al., “Effects of Halofenate on Glucose Tolerance in Patients with Hyperlipoproteinemia,” Journal Clinical Pharmacology, 1978, vol. 18, pp. 241-248.
Feldman, E.B., et al., “Insulin Sensitivity in Hypertriglyceridemia: induction by combined triglyceride and uric lowering,” Clinical Research, 1975, vol. 23, No. 1, pp. 43A.
Flier, J., “Insulin Receptors and Insulin Resistance,” Ann Rev. Med., 1983, vol. 34, pp. 145-161.
Friedberg, S.J., “The Control of Insulin Resistant and Refractory Type II Diabetes Mellitus by Means of Halofenate-Sulfonylurea Combined Regimen,” Clinical Research, 1986, vol. 34, pp. 682A.
Gavin III, J.R., et al., “Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus,” Diabetes Care, 1999, vol. 22, Supplement 1, pp. S5-S19.
Goetze, S., et al., “PPARy-Ligands Inhibit Migration Mediated by Multiple Chemoattractants in Vascular Smooth Muscle Cells,” Journal of Cardiovascular Pharmacology, 1999, vol. 33, pp. 798-806.
Howard, B., et al., “Lipoprotein Composition in Di
Metabolex Inc.
Townsend & Townsend & Crew LLP
Tucker Zachary C.
LandOfFree
Resolution of α-(phenoxy)phenylacetic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Resolution of α-(phenoxy)phenylacetic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Resolution of α-(phenoxy)phenylacetic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3738244